tiprankstipranks
Trending News
More News >
Advertisement

FEGE - ETF AI Analysis

Compare

Top Page

FEGE

First Eagle Global Equity ETF (FEGE)

Rating:63Neutral
Price Target:
FEGE’s rating suggests it is a solid but not top-tier global equity ETF, supported by strong positions in high-quality companies like Alphabet (GOOG), which benefits from robust profitability and long-term growth prospects in AI and cloud, and Barrick (B), which adds upside through strong financials and positive corporate actions. Other holdings such as Meta (META), Elevance Health (ELV), and British American Tobacco (GB:BATS) further support the fund with generally strong performance drivers, though issues like high valuations, regulatory and market pressures, and company-specific risks (for example, leverage at HCA and operational challenges at Imperial Oil) may limit the overall rating. The main risk factor is that several key holdings face valuation or operational headwinds, which could increase volatility even though the fund is diversified across sectors.
Positive Factors
Broad Global Reach
The fund invests across many countries, with meaningful exposure outside the U.S., which can help reduce reliance on a single market.
Balanced Sector Mix
Holdings are spread across defensive areas like consumer staples and health care as well as cyclical sectors, helping balance growth potential and stability.
Generally Solid Recent Performance
The ETF has shown steady gains over the past few months, suggesting its mix of holdings has been working well in the current market.
Negative Factors
Moderate Fee Level
The expense ratio is not especially low for an ETF, which means a noticeable slice of returns goes to fees each year.
Heavy U.S. Tilt
Although it is a global fund, a large majority of assets are in U.S. stocks, so investors may not get as much international diversification as the name suggests.
Mixed Performance Among Top Holdings
While several top positions have performed strongly, a few key names have been weak recently, which can create bumps in the fund’s overall returns.

FEGE vs. SPDR S&P 500 ETF (SPY)

FEGE Summary

The First Eagle Global Equity ETF (FEGE) is a global stock fund that looks for companies around the world that appear undervalued. It doesn’t track a specific index, but follows a value-investing theme, picking stocks from many countries and sectors, including the U.S., Europe, and Asia. Well-known holdings include Alphabet (Google’s parent company) and Meta Platforms (Facebook’s parent company). Investors might consider FEGE for broad international diversification and the potential for long-term growth by buying solid companies at attractive prices. A key risk is that stock values can go up and down, and value stocks can stay out of favor for long periods.
How much will it cost me?The First Eagle Global Equity ETF (FEGE) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, focusing on selecting undervalued global companies rather than tracking a passive index.
What would affect this ETF?The First Eagle Global Equity ETF (FEGE) could benefit from global economic growth and increased demand for value-oriented investments, especially in sectors like Consumer Defensive and Health Care, which are more resilient during economic uncertainty. However, it may face challenges from rising interest rates, which can pressure equity valuations, and geopolitical tensions that could disrupt global markets, particularly in regions where its holdings like TSM and Prosus operate.

FEGE Top 10 Holdings

FEGE’s story is less about flashy Big Tech and more about steady global workhorses. Alphabet is one of the key engines, rising on the back of strong AI and cloud momentum, while Meta has been losing steam lately and slightly dampening returns. Gold and resources are a clear theme: Barrick and Wheaton Precious Metals have been climbing, and Imperial Oil has also been a bright spot, giving the fund a lift from the commodities side. Health names like Becton Dickinson and Elevance are quietly steady, helping balance this globally diversified mix.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
British American Tobacco2.81%$36.91M£94.79B28.76%
71
Outperform
Alphabet Class C2.56%$33.58M$3.85T74.94%
82
Outperform
Becton Dickinson2.40%$31.49M$48.88B-7.83%
67
Neutral
HCA Healthcare2.18%$28.62M$114.56B54.55%
70
Neutral
Imperial Oil2.14%$28.08M$56.77B62.23%
72
Outperform
Meta Platforms2.07%$27.17M$1.70T-6.64%
76
Outperform
Schlumberger1.76%$23.12M$75.25B21.93%
75
Outperform
Merck KGaA1.65%$21.68M€54.59B-5.89%
76
Outperform
CH Robinson1.60%$20.95M$23.23B105.34%
72
Outperform
Elevance Health1.57%$20.65M$71.87B-16.37%
76
Outperform

FEGE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
47.42
Positive
100DMA
45.65
Positive
200DMA
42.79
Positive
Market Momentum
MACD
0.87
Negative
RSI
72.65
Negative
STOCH
96.22
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FEGE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 49.25, equal to the 50-day MA of 47.42, and equal to the 200-day MA of 42.79, indicating a bullish trend. The MACD of 0.87 indicates Negative momentum. The RSI at 72.65 is Negative, neither overbought nor oversold. The STOCH value of 96.22 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FEGE.

FEGE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.32B0.50%
$9.19B0.47%
$7.10B0.47%
$4.61B0.47%
$3.80B0.81%
$2.52B0.40%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FEGE
First Eagle Global Equity ETF
50.96
14.05
38.07%
CGGO
Capital Group Global Growth Equity ETF
JGLO
JPMorgan Global Select Equity ETF
CGDG
Capital Group Dividend Growers ETF
EAGL
Eagle Capital Select Equity ETF
BDYN
iShares Dynamic Equity Active ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement